Cargando…
The Anti-Nociception Effect of Dezocine in a Rat Neuropathic Pain Model
The treatment of neuropathic pain (NP) currently remains clinically challenging. In an attempt to identify novel targets of known opioids, we found that dezocine, a non-addictive opioid, inhibits norepinephrine and serotonin reuptake through their transporter proteins which open the potential for de...
Autores principales: | Wu, Fei-Xiang, Pan, Rui-Rui, Yu, Wei-Feng, Liu, Renyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209404/ https://www.ncbi.nlm.nih.gov/pubmed/25356434 |
Ejemplares similares
-
Overexpression of RAPGEF3 enhances the therapeutic effect of dezocine in treatment of neuropathic pain
por: Liu, Xue, et al.
Publicado: (2021) -
Additive analgesic effect of dexmedetomidine and dezocine administered intrathecally in a mouse pain model
por: Huang, Ya-Qin, et al.
Publicado: (2018) -
Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain
por: Wu, Fei-xiang, et al.
Publicado: (2010) -
Anti-nociceptive effects of dual neuropeptide antagonist therapy in mouse model of neuropathic and inflammatory pain
por: Kim, Min Su, et al.
Publicado: (2022) -
Gabapentin Enhances the Morphine Anti-Nociceptive Effect in Neuropathic Pain via the Interleukin-10-Heme Oxygenase-1 Signalling Pathway in Rats
por: Bao, Yu-Hua, et al.
Publicado: (2014)